Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)

Diego H Caceres; Laura C Echeverri Tirado; Alexandro Bonifaz; Antoine Adenis; Beatriz L Gomez; Claudia Lizette Banda Flores; Cristina E Canteros; Daniel Wagner Santos; Eduardo Arathoon; Elia Ramirez Soto; Flavio Queiroz-Telles; Ilan S Schwartz; Jeannete Zurita; Lisandra Serra Damasceno; Nataly Garcia; Norma B Fernandez; Omayra Chincha; Patricia Araujo; Ricardo Rabagliati; Tom Chiller; Gustavo Giusiano

doi:10.1111/myc.13510

Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)

Título traducido de la contribución: Situación actual de las micosis endémicas en las Américas y el Caribe: Actas de la primera reunión internacional sobre micosis endémicas de las Américas (IMEMA)

Diego H Caceres, Laura C Echeverri Tirado, Alexandro Bonifaz, Antoine Adenis, Beatriz L Gomez, Claudia Lizette Banda Flores, Cristina E Canteros, Daniel Wagner Santos, Eduardo Arathoon, Elia Ramirez Soto, Flavio Queiroz-Telles, Ilan S Schwartz, Jeannete Zurita, Lisandra Serra Damasceno, Nataly Garcia, Norma B Fernandez, Omayra Chincha, Patricia Araujo, Ricardo Rabagliati, Tom ChillerGustavo Giusiano

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

14 Citas (Scopus)

Resumen

Las Américas son el hogar de hongos endémicos biológica y clínicamente diversos, incluidos Blastomyces, Coccidioides , Emergomyces , Histoplasma, Paracoccidioides y Sporothrix . En zonas endémicas con alto riesgo de infección, estos hongos patógenos representan un importante problema de salud pública.

Objetivos
Este informe tiene como objetivo resumir los principales hallazgos del análisis regional realizado sobre el estado de las micosis endémicas de las Américas, realizado en la primera Reunión Internacional sobre Micosis Endémicas de las Américas (IMEMA).

Métodos
Se hizo un análisis regional para las Américas, los 27 territorios se agruparon en nueve regiones. Se realizó un análisis FODA.

Resultados
Todos los territorios informaron disponibilidad de microscopía. El setenta por ciento de los territorios informaron pruebas de anticuerpos y el 67% de los territorios informaron disponibilidad de pruebas de antígenos de Histoplasma . Ninguno de los territorios informó el uso de (1–3)-β-d-glucano. El 52 por ciento de los territorios informaron la disponibilidad de pruebas de PCR en los centros de referencia (principalmente para histoplasmosis). La mayoría de los territorios reportaron acceso a medicamentos como trimetoprim-sulfametoxazol, itraconazol, voriconazol y anfotericina B (AMB) desoxicolato. Muchos países tenían acceso limitado a la formulación liposomal de AMB y azoles más nuevos, como posaconazol e isavuconazol. La vigilancia de estas enfermedades fúngicas fue mínima.

Conclusiones
Surgió un consenso entre los participantes de la reunión, este grupo concluyó que las micosis endémicas son enfermedades desatendidas, y que debido a su gravedad y falta de recursos, es necesario mejorar el diagnóstico, tratamiento y vigilancia.

Título traducido de la contribución	Situación actual de las micosis endémicas en las Américas y el Caribe: Actas de la primera reunión internacional sobre micosis endémicas de las Américas (IMEMA)
Idioma original	Inglés estadounidense
Páginas (desde-hasta)	1179–1187
Número de páginas	9
Publicación	Mycoses
Volumen	65
N.º	12
DOI	https://doi.org/10.1111/myc.13510
Estado	Publicación electrónica previa a su impresión - jul. 30 2022

Áreas temáticas de ASJC Scopus

Microbiología (médica)

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1111/myc.13510

Citar esto

Caceres, D. H., Echeverri Tirado, L. C., Bonifaz, A., Adenis, A., Gomez, B. L., Flores, C. L. B., Canteros, C. E., Santos, D. W., Arathoon, E., Soto, E. R., Queiroz-Telles, F., Schwartz, I. S., Zurita, J., Damasceno, L. S., Garcia, N., Fernandez, N. B., Chincha, O., Araujo, P., Rabagliati, R., ... Giusiano, G. (2022). Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA). Mycoses, 65(12), 1179–1187. Avanzar publicación online. https://doi.org/10.1111/myc.13510

@article{e0c20c3a64ef4ff292f0d8f101394467,

title = "Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)",

abstract = "BACKGROUND: The Americas are home to biologically and clinically diverse endemic fungi, including Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides and Sporothrix. In endemic areas with high risk of infection, these fungal pathogens represent an important public health problem.OBJECTIVES: This report aims to summarise the main findings of the regional analysis carried out on the status of the endemic mycoses of the Americas, done at the first International Meeting on Endemic Mycoses of the Americas (IMEMA).METHODS: A regional analysis for the Americas was done, the 27 territories were grouped into nine regions. A SWOT analysis was done.RESULTS: All territories reported availability of microscopy. Seventy percent of territories reported antibody testing, 67% of territories reported availability of Histoplasma antigen testing. None of the territories reported the use of (1-3)-β-d-glucan. Fifty two percent of territories reported the availability of PCR testing in reference centres (mostly for histoplasmosis). Most of the territories reported access to medications such as trimethoprim-sulfamethoxazole, itraconazole, voriconazole and amphotericin B (AMB) deoxycholate. Many countries had limited access to liposomal formulation of AMB and newer azoles, such as posaconazole and isavuconazole. Surveillance of these fungal diseases was minimal.CONCLUSIONS: A consensus emerged among meeting participants, this group concluded that endemic mycoses are neglected diseases, and due to their severity and lack of resources, the improvement of diagnosis, treatment and surveillance is needed.",

author = "Caceres, {Diego H} and {Echeverri Tirado}, {Laura C} and Alexandro Bonifaz and Antoine Adenis and Gomez, {Beatriz L} and Flores, {Claudia Lizette Banda} and Canteros, {Cristina E} and Santos, {Daniel Wagner} and Eduardo Arathoon and Soto, {Elia Ramirez} and Flavio Queiroz-Telles and Schwartz, {Ilan S} and Jeannete Zurita and Damasceno, {Lisandra Serra} and Nataly Garcia and Fernandez, {Norma B} and Omayra Chincha and Patricia Araujo and Ricardo Rabagliati and Tom Chiller and Gustavo Giusiano",

note = "{\textcopyright} 2022 The Authors. Mycoses published by Wiley-VCH GmbH.",

year = "2022",

month = jul,

day = "30",

doi = "10.1111/myc.13510",

language = "English (US)",

volume = "65",

pages = "1179–1187",

journal = "Mycoses",

issn = "0933-7407",

publisher = "Wiley-Blackwell",

number = "12",

}

Caceres, DH, Echeverri Tirado, LC, Bonifaz, A, Adenis, A, Gomez, BL, Flores, CLB, Canteros, CE, Santos, DW, Arathoon, E, Soto, ER, Queiroz-Telles, F, Schwartz, IS, Zurita, J, Damasceno, LS, Garcia, N, Fernandez, NB, Chincha, O, Araujo, P, Rabagliati, R, Chiller, T & Giusiano, G 2022, 'Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)', Mycoses, vol. 65, n.º 12, pp. 1179–1187. https://doi.org/10.1111/myc.13510

Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA). / Caceres, Diego H; Echeverri Tirado, Laura C; Bonifaz, Alexandro et al.
En: Mycoses, Vol. 65, N.º 12, 30.07.2022, p. 1179–1187.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

TY - JOUR

T1 - Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)

AU - Caceres, Diego H

AU - Echeverri Tirado, Laura C

AU - Bonifaz, Alexandro

AU - Adenis, Antoine

AU - Gomez, Beatriz L

AU - Flores, Claudia Lizette Banda

AU - Canteros, Cristina E

AU - Santos, Daniel Wagner

AU - Arathoon, Eduardo

AU - Soto, Elia Ramirez

AU - Queiroz-Telles, Flavio

AU - Schwartz, Ilan S

AU - Zurita, Jeannete

AU - Damasceno, Lisandra Serra

AU - Garcia, Nataly

AU - Fernandez, Norma B

AU - Chincha, Omayra

AU - Araujo, Patricia

AU - Rabagliati, Ricardo

AU - Chiller, Tom

AU - Giusiano, Gustavo

PY - 2022/7/30

Y1 - 2022/7/30

N2 - BACKGROUND: The Americas are home to biologically and clinically diverse endemic fungi, including Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides and Sporothrix. In endemic areas with high risk of infection, these fungal pathogens represent an important public health problem.OBJECTIVES: This report aims to summarise the main findings of the regional analysis carried out on the status of the endemic mycoses of the Americas, done at the first International Meeting on Endemic Mycoses of the Americas (IMEMA).METHODS: A regional analysis for the Americas was done, the 27 territories were grouped into nine regions. A SWOT analysis was done.RESULTS: All territories reported availability of microscopy. Seventy percent of territories reported antibody testing, 67% of territories reported availability of Histoplasma antigen testing. None of the territories reported the use of (1-3)-β-d-glucan. Fifty two percent of territories reported the availability of PCR testing in reference centres (mostly for histoplasmosis). Most of the territories reported access to medications such as trimethoprim-sulfamethoxazole, itraconazole, voriconazole and amphotericin B (AMB) deoxycholate. Many countries had limited access to liposomal formulation of AMB and newer azoles, such as posaconazole and isavuconazole. Surveillance of these fungal diseases was minimal.CONCLUSIONS: A consensus emerged among meeting participants, this group concluded that endemic mycoses are neglected diseases, and due to their severity and lack of resources, the improvement of diagnosis, treatment and surveillance is needed.

AB - BACKGROUND: The Americas are home to biologically and clinically diverse endemic fungi, including Blastomyces, Coccidioides, Emergomyces, Histoplasma, Paracoccidioides and Sporothrix. In endemic areas with high risk of infection, these fungal pathogens represent an important public health problem.OBJECTIVES: This report aims to summarise the main findings of the regional analysis carried out on the status of the endemic mycoses of the Americas, done at the first International Meeting on Endemic Mycoses of the Americas (IMEMA).METHODS: A regional analysis for the Americas was done, the 27 territories were grouped into nine regions. A SWOT analysis was done.RESULTS: All territories reported availability of microscopy. Seventy percent of territories reported antibody testing, 67% of territories reported availability of Histoplasma antigen testing. None of the territories reported the use of (1-3)-β-d-glucan. Fifty two percent of territories reported the availability of PCR testing in reference centres (mostly for histoplasmosis). Most of the territories reported access to medications such as trimethoprim-sulfamethoxazole, itraconazole, voriconazole and amphotericin B (AMB) deoxycholate. Many countries had limited access to liposomal formulation of AMB and newer azoles, such as posaconazole and isavuconazole. Surveillance of these fungal diseases was minimal.CONCLUSIONS: A consensus emerged among meeting participants, this group concluded that endemic mycoses are neglected diseases, and due to their severity and lack of resources, the improvement of diagnosis, treatment and surveillance is needed.

U2 - 10.1111/myc.13510

DO - 10.1111/myc.13510

M3 - Article

C2 - 35971917

SN - 0933-7407

VL - 65

SP - 1179

EP - 1187

JO - Mycoses

JF - Mycoses

IS - 12

ER -

Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)

Resumen

Áreas temáticas de ASJC Scopus

ODS de las Naciones Unidas

Acceder al documento

Huella

Citar esto